These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 38459407)

  • 21. Stem Cell Therapy for Epidermolysis Bullosa-Does It Work?
    Tamai K; Uitto J
    J Invest Dermatol; 2016 Nov; 136(11):2119-2121. PubMed ID: 27772543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current topics in Epidermolysis bullosa: Pathophysiology and therapeutic challenges.
    Natsuga K; Shinkuma S; Hsu CK; Fujita Y; Ishiko A; Tamai K; McGrath JA
    J Dermatol Sci; 2021 Dec; 104(3):164-176. PubMed ID: 34916041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy in combination with tissue engineering to treat epidermolysis bullosa.
    Ferrari S; Pellegrini G; Matsui T; Mavilio F; De Luca M
    Expert Opin Biol Ther; 2006 Apr; 6(4):367-78. PubMed ID: 16548763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplantation of a New Biological Product in Rare Diseases, Such as Epidermolysis Bullosa: Response and Clinical Outcome.
    Pliszczyński J; Nita M; Kowalewski C; Woźniak K; Eljaszewicz A; Moniuszko M; Kamiński A; Śladowski D; Zimek Z; Majewski S; Kosieradzki M; Fiedor P
    Transplant Proc; 2020 Sep; 52(7):2239-2243. PubMed ID: 32334796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated Management Strategies for Epidermolysis Bullosa: Current Insights.
    Sait H; Srivastava S; Saxena D
    Int J Gen Med; 2022; 15():5133-5144. PubMed ID: 35637703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa.
    De Rosa L; Enzo E; Zardi G; Bodemer C; Magnoni C; Schneider H; De Luca M
    Front Genet; 2021; 12():705019. PubMed ID: 34539738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular therapy options for genetic skin disorders with a focus on recessive dystrophic epidermolysis bullosa.
    Naso G; Petrova A
    Br Med Bull; 2020 Dec; 136(1):30-45. PubMed ID: 32888294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential of gene therapy for recessive dystrophic epidermolysis bullosa.
    Subramaniam KS; Antoniou MN; McGrath JA; Lwin SM
    Br J Dermatol; 2022 Apr; 186(4):609-619. PubMed ID: 34862606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of the Latest Methods of Epidermolysis Bullosa and Other Chronic Wounds Treatment Including BIOOPA Dressing.
    Nita M; Pliszczyński J; Kosieradzki M; Fiedor P
    Dermatol Ther (Heidelb); 2021 Oct; 11(5):1469-1480. PubMed ID: 34269966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermolysis Bullosa: A Review of the Tissue-Engineered Skin Substitutes Used to Treat Wounds.
    du Rand A; Hunt JMT; Feisst V; Sheppard HM
    Mol Diagn Ther; 2022 Nov; 26(6):627-643. PubMed ID: 36251245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa.
    Tolar J; Xia L; Riddle MJ; Lees CJ; Eide CR; McElmurry RT; Titeux M; Osborn MJ; Lund TC; Hovnanian A; Wagner JE; Blazar BR
    J Invest Dermatol; 2011 Apr; 131(4):848-56. PubMed ID: 21124339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful therapeutic transplantation of revertant skin in epidermolysis bullosa.
    Gostyński A; Pasmooij AM; Jonkman MF
    J Am Acad Dermatol; 2014 Jan; 70(1):98-101. PubMed ID: 24176523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The utility of dermal fibroblasts in treatment of skin disorders: A paradigm of recessive dystrophic epidermolysis bullosa.
    Shams F; Rahimpour A; Vahidnezhad H; Hosseinzadeh S; Moravvej H; Kazemi B; Rajabibazl M; Abdollahimajd F; Uitto J
    Dermatol Ther; 2021 Jul; 34(4):e15028. PubMed ID: 34145697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes.
    Nakayama C; Fujita Y; Matsumura W; Ujiie I; Takashima S; Shinkuma S; Nomura T; Abe R; Shimizu H
    J Dermatol Sci; 2018 Sep; 91(3):301-310. PubMed ID: 29933899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermolysis bullosa: prospects for cell-based therapies.
    Uitto J
    J Invest Dermatol; 2008 Sep; 128(9):2140-2. PubMed ID: 18695685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leading edge: emerging drug, cell, and gene therapies for junctional epidermolysis bullosa.
    Keith AR; Twaroski K; Ebens CL; Tolar J
    Expert Opin Biol Ther; 2020 Aug; 20(8):911-923. PubMed ID: 32178539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa.
    Rashidghamat E; McGrath JA
    Intractable Rare Dis Res; 2017 Feb; 6(1):6-20. PubMed ID: 28357176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of Skin Lesions in Patients with Epidermolysis Bullosa by Topical Treatment: Systematic Review and Meta-Analysis.
    Pabón-Carrasco M; Caceres-Matos R; Roche-Campos M; Hurtado-Guapo MA; Ortiz-Romero M; Gordillo-Fernández LM; Pabón-Carrasco D; Castro-Méndez A
    Healthcare (Basel); 2024 Jan; 12(2):. PubMed ID: 38275540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hereditary blistering diseases. Symptoms, diagnosis and treatment of epidermolysis bullosa].
    Laimer M; Lanschützer CM; Nischler E; Klausegger A; Diem A; Pohla-Gubo G; Bauer JW; Hintner H
    Hautarzt; 2009 May; 60(5):378-88. PubMed ID: 19430749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A scalable, GMP-compatible, autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa.
    Neumayer G; Torkelson JL; Li S; McCarthy K; Zhen HH; Vangipuram M; Jackow J; Rami A; Hansen C; Guo Z; Gaddam S; Pappalardo A; Li L; Cramer A; Roy KR; Nguyen TM; Tanabe K; McGrath PS; Bruckner A; Bilousova G; Roop D; Bailey I; Tang JY; Christiano A; Steinmetz LM; Wernig M; Oro AE
    bioRxiv; 2023 Mar; ():. PubMed ID: 36909618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.